Literature DB >> 21686620

Ventricular tachycardia as the first manifestation of cardiac sarcoidosis.

Felix Mehrhof1, Martin Stockburger, Hartwig Schuette, Wilhelm Haverkamp, Rainer Dietz.   

Abstract

The case of a 32-year-old man with sustained ventricular tachycardia and hypotension is described. Following pharmacological treatment the patient switched to a sinus rhythm and was transferred to a university hospital for further diagnostic procedures and treatment. Cardiac catherisation ruled out underlying coronary artery disease, and cardiac MRI as well as echocardiography demonstrated a moderately reduced left ventricular ejection fraction, marked thickening of the interventricular septum and extensive intramural and epicardial infiltration of both ventricles. Endomyocardial biopsies were inconclusive; an implantable cardioverter defibrillator (ICD) was implanted in order to prevent a fatal arrhythmic event. Only repeated lymph node biopsies revealed typical findings of granulomatous disease, which together with the clinical course and the cardiac MRI findings strongly supported cardiac sarcoidosis. A few days after initiation of therapy with corticosteroids, the patient experienced the first of a number of ICD discharges, demanding aggressive anti-arrhythmic treatment regimen for the future.

Entities:  

Year:  2009        PMID: 21686620      PMCID: PMC3028065          DOI: 10.1136/bcr.08.2008.0810

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  33 in total

Review 1.  Cardiac sarcoidosis.

Authors:  Abdul R Doughan; Byron R Williams
Journal:  Heart       Date:  2006-02       Impact factor: 5.994

2.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Europace       Date:  2006-08-25       Impact factor: 5.214

3.  Case report: Cardiac sarcoidosis presenting with ventricular arrhythmias: case report and review of the literature.

Authors:  Masanori Mori; Sam Hanon; Maurice Rachko
Journal:  Int J Cardiol       Date:  2007-06-22       Impact factor: 4.164

4.  Recurrence of cardiac sarcoidosis in a heart transplant recipient.

Authors:  Jonathan E E Yager; Adrian F Hernandez; Charles Steenbergen; Bradley Persing; Stuart D Russell; Carmelo Milano; G Michael Felker
Journal:  J Heart Lung Transplant       Date:  2005-08-19       Impact factor: 10.247

5.  Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study.

Authors:  Olivier Vignaux; Robin Dhote; Denis Duboc; Philippe Blanche; Daniel Dusser; Simon Weber; Paul Legmann
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

6.  Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.

Authors:  Anthony Aizer; Eric H Stern; J Anthony Gomes; Alvin S Teirstein; Robert E Eckart; Davendra Mehta
Journal:  Am J Cardiol       Date:  2005-07-15       Impact factor: 2.778

7.  Cardiac sarcoidosis: a retrospective study of 41 cases.

Authors:  Catherine Chapelon-Abric; Dominique de Zuttere; Pierre Duhaut; Pierre Veyssier; Bertrand Wechsler; Du Le Thi Huong; Christian de Gennes; Thomas Papo; Olivier Blétry; Pierre Godeau; Jean-Charles Piette
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

8.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors:  Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057

9.  Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone.

Authors:  Y Yazaki; M Isobe; M Hiroe; S Morimoto; S Hiramitsu; T Nakano; T Izumi; M Sekiguchi
Journal:  Am J Cardiol       Date:  2001-11-01       Impact factor: 2.778

10.  Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.

Authors:  Hiroyuki Yamagishi; Naoya Shirai; Masahiko Takagi; Minoru Yoshiyama; Kaname Akioka; Kazuhide Takeuchi; Junichi Yoshikawa
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.